(BBH) Holdings - VanEck Biotech

Potfolio Holdings BBH, Valuations and Growth Rates, Asset Allocations, Country and Market Cap Distributions.

BBH Top Holdings (24)

Symbol Name Sector Industry Country Assets %
AMGN NASDAQ
Amgen
Amgen Inc Healthcare Drug Manufacturers - General United States US
North America
17.41%
GILD NASDAQ
Gilead Sciences
Gilead Sciences Inc Healthcare Drug Manufacturers - General United States US
North America
13.4%
VRTX NASDAQ
Vertex Pharmaceuticals
Vertex Pharmaceuticals Inc Healthcare Biotechnology United States US
North America
11.84%
REGN NASDAQ
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals Inc Healthcare Biotechnology United States US
North America
6.27%
ARGX NASDAQ
argenx
argenx NV ADR Healthcare Biotechnology United States US
North America
5.16%
NTRA NASDAQ
Natera
Natera Inc Healthcare Diagnostics & Research United States US
North America
4.32%
IQV NYSE
IQVIA Holdings
IQVIA Holdings Inc Healthcare Diagnostics & Research United States US
North America
4.29%
ALNY NASDAQ
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Inc Healthcare Biotechnology United States US
North America
3.73%
ICLR NASDAQ
ICON
ICON PLC Healthcare Diagnostics & Research United States US
North America
3.26%
BIIB NASDAQ
Biogen
Biogen Inc Healthcare Drug Manufacturers - General United States US
North America
3.01%
ILMN NASDAQ
Illumina
Illumina Inc Healthcare Diagnostics & Research United States US
North America
2.79%
BNTX NASDAQ
BioNTech SE
BioNTech SE Healthcare Biotechnology United States US
North America
2.5%
BGNE BeiGene Ltd Healthcare Biotechnology United States US
North America
2.39%
INSM NASDAQ
Insmed
Insmed Inc Healthcare Biotechnology United States US
North America
2.25%
NBIX NASDAQ
Neurocrine Biosciences
Neurocrine Biosciences Inc Healthcare Drug Manufacturers - Specialty... United States US
North America
2.17%
MRNA NASDAQ
Moderna
Moderna Inc Healthcare Biotechnology United States US
North America
2.02%
SRPT NASDAQ
Sarepta Therapeutics
Sarepta Therapeutics Inc Healthcare Biotechnology United States US
North America
1.93%
TECH NASDAQ
Bio-Techne
Bio-Techne Corp Healthcare Biotechnology United States US
North America
1.79%
INCY NASDAQ
Incyte
Incyte Corporation Healthcare Biotechnology United States US
North America
1.66%
CRL NYSE
Charles River Laboratories
Charles River Laboratories Healthcare Diagnostics & Research United States US
North America
1.59%
RGEN NASDAQ
Repligen
Repligen Corporation Healthcare Medical Instruments & Supplies United States US
North America
1.4%
BMRN NASDAQ
Biomarin Pharmaceutical
Biomarin Pharmaceutical Inc Healthcare Biotechnology United States US
North America
1.4%
EXAS NASDAQ
EXACT Sciences
EXACT Sciences Corporation Healthcare Diagnostics & Research United States US
North America
1.17%
CYTK NASDAQ
Cytokinetics
Cytokinetics Inc Healthcare Biotechnology United States US
North America
0.62%

BBH Sectors

Equity % Relative to Category
Basic Materials 0% 0%
Consumer Cyclicals 0% 0%
Financial Services 0% 0.05%
Real Estate 0% 0.11%
Communication Services 0% 0%
Energy 0% 0.02%
Industrials 0% 0.04%
Technology 0% 0%
Consumer Defensive 0% 0.06%
Healthcare 100% 99.72%
Utilities 0% 0%

BBH Valuations and Growth Rates

Valuations Rates Portfolio Valuations Rates To Category Growth Rates Portfolio Growth Rates To Category
Price/Prospective Earnings 16.33 21.05
Price/Book 4.58 5.06
Price/Sales 4.59 2.96
Price/Cash Flow 13.85 19.71
Dividend-Yield Factor 1.06 0.97
Long-Term Projected Earnings Growth 5.51 11.4
Historical Earnings Growth -14.07 -1.12
Sales Growth 3.32 9.74
Cash-Flow Growth -9.04 -6.38
Book-Value Growth 5.16 7.58

BBH Country Distribution

Equity % Relative to Category
North America 95.1% 90.83%
United Kingdom 0% 1.91%
Europe Developed 2.51% 6.14%
Europe Emerging 0% 0%
Africa/Middle East 0% 0.2%
Japan 0% 0.46%
Australasia 0% 0.09%
Asia Developed 0% 0.03%
Asia Emerging 2.4% 0.35%
Latin America 0% 0%

BBH Asset Allocations

Long % Short % Net Assets %
Cash 0.09% 0% 0.09%
NotClassified 0% 0% 0%
Stock non-US 4.9% 0% 4.9%
Other 0% 0% 0%
Stock US 95.02% 0% 95.02%
Bond 0% 0% 0%

BBH Market Cap Distribution of Holdings

Mega Big Medium Small Micro
2.39% 48.92% 37.85% 8.25% 0%